HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7

[1]  K. Strebel,et al.  Vpr and Its Cellular Interaction Partners: R We There Yet? , 2019, Cells.

[2]  P. Lehner,et al.  Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection , 2019, Cell reports.

[3]  Junpeng Yan,et al.  HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells , 2019, Proceedings of the National Academy of Sciences.

[4]  F. Margottin-Goguet,et al.  HIV-2/SIV viral protein X counteracts HUSH repressor complex , 2018, Nature Microbiology.

[5]  Y. Xiong,et al.  Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication. , 2018, Molecular cell.

[6]  J. Luban,et al.  Primate immunodeficiency virus Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex , 2018, bioRxiv.

[7]  Xiaohong Zhou,et al.  HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase , 2017, The Journal of Biological Chemistry.

[8]  Y. Xiong,et al.  SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes , 2017, The FEBS journal.

[9]  Shihab U. Sobuz,et al.  Sirtuin 7-dependent deacetylation of DDB1 regulates the expression of nuclear receptor TR4. , 2017, Biochemical and biophysical research communications.

[10]  Bizhan Romani,et al.  Underlying mechanisms of HIV-1 latency , 2017, Virus Genes.

[11]  B. Vazquez,et al.  Sirtuins and DNA damage repair: SIRT7 comes to play , 2017, Nucleus.

[12]  I. Grummt,et al.  The seven faces of SIRT7 , 2017, Transcription.

[13]  A. Gronenborn,et al.  The DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction , 2016, Nature Structural &Molecular Biology.

[14]  M. Aghasadeghi,et al.  HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin , 2016, Scientific Reports.

[15]  Katrin F Chua,et al.  SIRT7 clears the way for DNA repair , 2016, The EMBO journal.

[16]  Xiaohong Zhou,et al.  SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr)*♦ , 2016, The Journal of Biological Chemistry.

[17]  J. Tischfield,et al.  SIRT7 promotes genome integrity and modulates non‐homologous end joining DNA repair , 2016, The EMBO journal.

[18]  M. Aghasadeghi,et al.  HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages* , 2015, The Journal of Biological Chemistry.

[19]  Xia Li,et al.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.

[20]  A. Gronenborn,et al.  Structural Basis of Clade-specific Engagement of SAMHD1 (Sterile α Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by Lentiviral Viral Protein X (Vpx) Virulence Factors* , 2015, Journal of Biological Chemistry.

[21]  I. Taylor,et al.  Molecular Determinants for Recognition of Divergent SAMHD1 Proteins by the Lentiviral Accessory Protein Vpx , 2015, Cell host & microbe.

[22]  K. Tomizawa,et al.  SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. , 2014, Cell metabolism.

[23]  Silvana Paredes,et al.  Molecular Pathways: Emerging Roles of Mammalian Sirtuin SIRT7 in Cancer , 2014, Clinical Cancer Research.

[24]  David R. Collins,et al.  HIV-1 Accessory Proteins Adapt Cellular Adaptors to Facilitate Immune Evasion , 2014, PLoS pathogens.

[25]  I. Taylor,et al.  Structural basis of lentiviral subversion of a cellular protein degradation pathway , 2013, Nature.

[26]  W. Greene,et al.  An Integrated Overview of HIV-1 Latency , 2013, Cell.

[27]  É. Cohen,et al.  Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase. , 2012, Current opinion in virology.

[28]  A. Vaquero,et al.  A big step for SIRT7, one giant leap for Sirtuins… in cancer. , 2012, Cancer cell.

[29]  Kevin Struhl,et al.  SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation , 2012, Nature.

[30]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[31]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[32]  Francine C. A. Gérard,et al.  Formation of Mobile Chromatin-Associated Nuclear Foci Containing HIV-1 Vpr and VPRBP Is Critical for the Induction of G2 Cell Cycle Arrest , 2010, PLoS pathogens.

[33]  Michael Emerman,et al.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.

[34]  C. Van Lint,et al.  Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation. , 1996, The EMBO journal.